0001354457-23-000143.txt : 20230303
0001354457-23-000143.hdr.sgml : 20230303
20230303104423
ACCESSION NUMBER: 0001354457-23-000143
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Metacrine, Inc.
CENTRAL INDEX KEY: 0001634379
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472297384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39512
BUSINESS ADDRESS:
STREET 1: 4225 EXECUTIVE SQUARE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-369-7800
MAIL ADDRESS:
STREET 1: 4225 EXECUTIVE SQUARE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92037
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001634379
Metacrine, Inc.
001-39512
3985 Sorrento Valley Blvd.
Suite C
San Diego
CA
CALIFORNIA
92121
858-369-7837
Common Stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-03-03
EX-99.25
2
mtcrdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, March 3, 2023,
Metacrine, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of Metacrine, Inc., effective at the
opening of the trading session on March 13, 2023.
Based on review of information provided by the Company, Exchange Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5550(a)(2).
The Company was notified of the Staff determination on January 31,
2023. The Company did not appeal the Staff determination to the Hearings
Panel. The Staff determination to delist the Company securities became
final on February 9, 2023.